Cooper BR - Search Results

1

Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.

Norman MH, Rigdon GC, Navas F 3rd, Cooper BR. Norman MH, et al. Among authors: cooper br. J Med Chem. 1994 Aug 5;37(16):2552-63. doi: 10.1021/jm00042a008. J Med Chem. 1994. PMID: 7914539

2

1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects.

Rigdon GC, Norman MH, Cooper BR, Howard JL, Boncek VM, Faison WL, Nanry KP, Pollard GT. Rigdon GC, et al. Among authors: cooper br. Neuropsychopharmacology. 1996 Sep;15(3):231-42. doi: 10.1016/0893-133X(95)00239-A. Neuropsychopharmacology. 1996. PMID: 8873106

3

Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.

Ferris RM, Brieaddy L, Mehta N, Hollingsworth E, Rigdon G, Wang C, Soroko F, Wastila W, Cooper B. Ferris RM, et al. J Pharm Pharmacol. 1995 Sep;47(9):775-81. doi: 10.1111/j.2042-7158.1995.tb06740.x. J Pharm Pharmacol. 1995. PMID: 8583392

4

6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents.

Kelley JL, Bullock RM, Krochmal MP, McLean EW, Linn JA, Durcan MJ, Cooper BR. Kelley JL, et al. Among authors: cooper br. J Med Chem. 1997 Sep 26;40(20):3207-16. doi: 10.1021/jm960662s. J Med Chem. 1997. PMID: 9379440

5

1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity.

Kelley JL, Koble CS, Davis RG, McLean EW, Soroko FE, Cooper BR. Kelley JL, et al. Among authors: cooper br. J Med Chem. 1995 Sep 29;38(20):4131-4. doi: 10.1021/jm00020a030. J Med Chem. 1995. PMID: 7562950

6

Synthesis and anticonvulsant activity of N-benzylpyrrolo[2,3-d]-, -pyrazolo[3,4-d]-, and -triazolo[4,5-d]pyrimidines: imidazole ring-modified analogues of 9-(2-fluorobenzyl)-6-(methylamino)-9H-purine.

Kelley JL, Davis RG, McLean EW, Glen RC, Soroko FE, Cooper BR. Kelley JL, et al. Among authors: cooper br. J Med Chem. 1995 Sep 15;38(19):3884-8. doi: 10.1021/jm00019a019. J Med Chem. 1995. PMID: 7562920

7

8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity.

Kelley JL, Linn JA, Bankston DD, Burchall CJ, Soroko FE, Cooper BR. Kelley JL, et al. Among authors: cooper br. J Med Chem. 1995 Sep 1;38(18):3676-9. doi: 10.1021/jm00018a029. J Med Chem. 1995. PMID: 7658456

8

(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.

Kelley JL, Musso DL, Boswell GE, Soroko FE, Cooper BR. Kelley JL, et al. Among authors: cooper br. J Med Chem. 1996 Jan 19;39(2):347-9. doi: 10.1021/jm950630p. J Med Chem. 1996. PMID: 8558500 No abstract available.

9

Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.

Jones-Humble SA, Durcan MJ, Lyerly D, Norton RM, Tang FL, Russell AV, Watson MJ, Gengo PJ, Morgan PF, Wang CM, Cooper BR, Cox RF. Jones-Humble SA, et al. Among authors: cooper br. Neuropsychopharmacology. 1996 Sep;15(3):217-30. doi: 10.1016/0893-133X(96)00019-X. Neuropsychopharmacology. 1996. PMID: 8873105

10

The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease.

Jones-Humble SA, Morgan PF, Cooper BR. Jones-Humble SA, et al. Among authors: cooper br. Life Sci. 1994;54(4):245-52. doi: 10.1016/0024-3205(94)00813-2. Life Sci. 1994. PMID: 8289584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters